Respiratory failure in systemic sclerosis
Authors:
- Joaquim Ivo Vasques Dantas LandimJLJoaquim Ivo Vasques Dantas Landim
- Andre Silva FrancoAFAndre Silva Franco
- Percival Degrava Sampaio-BarrosPSPercival Degrava Sampaio-Barros
- Renata MiossiRMRenata Miossi
- Ana Cristina Medeiros-RibeiroAMAna Cristina Medeiros-Ribeiro
- Rosa Maria R. PereiraRPRosa Maria R. Pereira
- Ana Paula Luppino AssadAAAna Paula Luppino Assad
- 14 October 2023
- journal article
- review article
- Published by Springer Nature in Rheumatology International
- Vol. 44 (11) , 2653-2658
Abstract
Systemic sclerosis (SSc) can lead to dyspnea and respiratory failure through multiple mechanisms, making a precise diagnosis particularly challenging, especially amid the current COVID-19 pandemic. In this report, we present a case involving a 26-year-old female who had previously undiagnosed SSc. She experienced acute respiratory failure necessitating orotracheal intubation. Following an extensive evaluation, the patient exhibited skin thickening, kidney failure, thrombocytopenia, microangiopathic anemia, and an antinuclear antibody with a nuclear fine speckled pattern at a titer of 1:320. A diagnosis of SSc complicated by scleroderma renal crisis (SRC) was established. The patient’s condition improved after undergoing hemodialysis, receiving an angiotensin-converting enzyme inhibitor, and undergoing cyclophosphamide treatment. Subsequently, she demonstrated sustained improvement during a follow-up period of 20 months.Keywords
This publication has 17 references indexed in Scilit:
- Predictors of progression in systemic sclerosis patients with interstitial lung diseaseEuropean Respiratory Journal, 2020
- Comorbidity burden in systemic sclerosis: beyond disease-specific complicationsRheumatology International, 2019
- Management of scleroderma renal crisisCurrent Opinion in Rheumatology, 2019
- Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ ComplicationThe Journal of Rheumatology, 2019
- Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR StudyPLOS ONE, 2016
- Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective studyAnnals of the Rheumatic Diseases, 2016
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the Rheumatic Diseases, 2010
- Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositisRheumatic Disease Clinics of North America, 2003
- Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisisArthritis & Rheumatism, 1998
- Anti-RNA polymerases and other autoantibody specificities in systemic sclerosisRheumatology, 1998